Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation

Pathology Research and Practice

Volumn 205, Issue 7, 2009, Pages 466-472

  Barroca, H ^a   Castedo, S ^b   Vieira, J ^c   Teixeira, M ^c   Muller Hocker J ^d  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b Centro de Genética Médica e Diagnóstico Pré Natal   (Portugal)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell cycle regulators; Pediatric; Renal carcinoma; TFE3

Indexed keywords

CARBOPLATIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; KI 67 ANTIGEN; PROTEIN MDM2; PROTEIN P53; PROTEIN P63; PROTEIN TFE3; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

AGE; ARTICLE; CASE REPORT; CELL CYCLE REGULATION; CHILD; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION X; CHROMOSOME XP; CLEAR CELL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; NEEDLE BIOPSY; NEPHRECTOMY; PROTEIN EXPRESSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CELL CYCLE PROTEINS; CHILD; CHROMOSOMES, HUMAN, X; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KIDNEY NEOPLASMS; NEPHRECTOMY; PHENOTYPE; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 67349099168     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.01.005     Document Type: Article

References (27)

1. (wafl/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br. J. Cancer 80 (1999) 2001-2007
2. Argani P., Antonescu C.R., Illei P.B., et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumour entity previously included among renal cell carcinoma of children and adolescents. Am. J. Pathol. 159 (2001) 179-192
3. Argani P., and Landanyi M. Distinctive neoplasms characterized by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas. Pathology 35 (2003) 492-498
4. (wafl/cip1) protein. Int. J. Gynecol. Pathol. 16 (1997) 361-368
5. Barroca H., Correia C., and Castedo S. Paediatric renal cell carcinoma associated with t(X;17). Cytological and cytogenetic diagnosis. Report of a case. Acta Cythol. 52 (2008) 384-386
6. Barroca H., Farinha N., and Carvalho J.L. Renal-cell carcinoma: cytologic diagnosis in a child. Diagn. Cytopathol. 21 (1999) 362
7. L. Bernstein, M. Linet, M.A. Smith, et al., Renal tumors, in: L.A.G. Ries, M.A. Smith, J.G. Gurney (Eds.), Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, SEER Program, National Cancer Institute, Bethesda, MD, 1999, pp. 79-90.
8. Bruder E., Passera O., Harms D., et al. Morphological and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 28 (2004) 1117-1132
9. Camparo P., Vasiliu V., Molinie V., Couturier J., Dykema K.J., et al. Renal translocation carcinomas. Clinicopathological, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am. J. Surg. Pathol. 35 (2008) 656-670
10. J.N. Eble, G. Sauter, J.L. Epstein, et al. (Eds.), Tumours of the kidney, WHO classification of tumours: tumors of the kidney, in: Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, France, 2004, pp. 37-38.
11. Gnarra J.R., Tory K., Weng Y., et al. Mutations of VHL tumours suppressor gene in renal carcinoma. Nat. Genet. 7 (1994) 85-90
12. kip1 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D. Int. J. Cancer 102 (2002) 601-607
13. kip1 in human renal cell carcinoma analyzed by tissue micro array. Br. J. Cancer 88 (2003) 1417-1423
14. Heimann P., El Housni H., Ogur G., et al. Fusion of a novel gene RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas. Cancer Res. 61 (2001) 4130-4135
15. Kawauchi S., Goto Y., Liu X.P., Furuya T., Oga A., Oda Y., Tsuneyoshi M., Ihara K., and Sasaki K. Low expression of p27 (Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma. Cancer 91 (2001) 1005-1012
16. Kuehn A., Paner G.P., Skinnider B.F., Cohen C., Datta M.W., Young A.N., Srigley J.R., and Amin M.B. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Am. J. Surg. Pathol. 31 (2007) 1528-1533
17. (wafl/cip1) protein in transitional cell bladder tumours and its prognostic value. Eur. Urol. 34 (1998) 237-243
18. kip1 is associated with tumour size and poor prognosis in patients with renal cell carcinoma. Cancer 94 (2002) 973-979
19. Moch H., Schraml P., Bubendorf L., et al. Intratumoral heterogeneity of Von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res. 58 (1998) 2304-2309
20. Müller-Höcker J., Babaryka G., Schmid I., and Jung A. Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion. Pathol. Res. Pract. 204 (2008) 589-597
21. Perot C., Boccon-Gibod L., Bouvier R., et al. Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study. Cancer Genet. Cytogenet. 143 (2003) 93-99
22. Phuoc N.B., Ehara H., Takahiro G., Masahiro N., Shigeaki Y., Deguchi T., and Hirose Y. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. J. Urol. 69 (2007) 843-848
23. Rakheja D., Kapur P., Tomlinson G.E., and Margraf L.R. Pediatric renal cell carcinomas with Xp11.2 rearrangements are immunoreactive for HMLH1 and hMSH2 proteins. Pediatr. Dev. Pathol. 8 (2005) 615-620
24. Shen S.S., Krishna B., Chirala R., Amato R.J., and Truong L.D. Kidney-specific cadherin, a specific marker for distal portion of the nephron and related renal neoplasms. Mod. Pathol. 18 (2005) 933-940
25. Sidhar S.K., Clark J., Gill S., et al. The t(X; 1) (p11.2; q21.2) translocation papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum. Mol. Genet. 5 (1996) 1333-1338
26. (wafl/cip1) in colorectal adenomas and adenocarcinomas and its action with p53 protein expression stage. Pathol. Int. 47 (1997) 470-477
27. Zambrano E., and Reyes-Mugica M. Renal cell carcinoma with t(X;17): singular pediatric neoplasm with specific phenotype/genotype features. Pediatr. Dev. Pathol. 6 (2002) 84-87